SCHEMBL6138068

SCHEMBL6138068

Cc1ccc(C(=O)N(CCCN(C)C)C(=N)N)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
UTS2R Q9UKP6 5/20 0.36
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.35
ALOX15 P16050 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NQO2 P16083 1/20 0.35
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6138031 0.85 CA1 (0.45) NPC1KMT2AUTS2RCA2POLB
SCHEMBL8286124 0.78 CDK4 (0.48) NPC1KMT2ACA12CA2CA9
SCHEMBL6137840 0.74 SCN5A (0.49) NPC1KMT2ARAB9ALMNAMAPT
SCHEMBL6137702 0.73 MEN1 (0.47) NPC1KMT2ARAB9AGAAALDH1A1
SCHEMBL9368117 0.72 ALDH1A1 (0.46) NPC1KMT2ARAB9AGAAALDH1A1
SCHEMBL8582839 0.72 HPGD (0.44) NPC1RAB9AGAAALDH1A1CES2
SCHEMBL19190075 0.71 HPGD (0.47) KMT2AUTS2RALDH1A1LMNACES2
SCHEMBL12237841 0.71 CDK4 (0.50) UTS2RALDH1A1LMNACES2CES1
Hydrochloric Acid SCHEMBL8767653 0.70 GRIN2D (0.41) NPC1RAB9AGAAALDH1A1LMNA
Hydrochloric Acid SCHEMBL8767719 0.70 CA1 (0.45) KMT2ACA2CES2CES1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP disclosed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP disclosed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO disclosed